ライフサイエンスコーパス: GPCR

1 GPCRs are challenging targets for conventional antibody

2 GPCRs are characterized by a seven-transmembrane alpha-h

3 GPCRs are the largest family of membrane proteins encode

4 GPCRs did not activate p110gamma in neutrophils from mic

5 GPCRs modulate several members of the transient receptor

6 rotein-coupled receptors (GPCRs) - nearly 50 GPCR peptide drugs have been approved to date, most of t

7 formation of the alpha(1A)-adrenoreceptor, a GPCR that stimulates smooth muscle contraction in respon

8 fying beta-arrestin-dependent signaling by a GPCR.

9 ric antrum, marked by expression of Cck2r (a GPCR) and Delta-like ligand 1 (DLL1), is a label-retaini

10 gnaling 6 (RGS6) revealed that RGS6 exerts a GPCR-dependent influence on GIRK-dependent signaling in

11 Smoothened (SMO) is a GPCR that mediates hedgehog signaling.

12 Although class A GPCRs are capable of activating G proteins in a monomeri

13 esidue is relatively conserved among class A GPCRs, and analogous mutations within other GPCRs simila

14 similarities in overall topology to class A GPCRs, but the transmembrane helix H4 is shifted by more

15 that an allosteric modulator of many class A GPCRs, Na(+), synergistically regulated pH sensing by ma

16 reening experiment against 224 human Class A GPCRs, where MAGELLAN achieved a median enrichment facto

17 t dependence on PIP(2) compared with class A GPCRs.

18 ane segment 6 (TM6) not observed in family A GPCRs.

19 Here we optimized the GRAB(ACh) (GPCR-activation-based ACh) sensor to achieve substantial

20 ve our understanding of other self-activated GPCRs, enable the identification of endogenous and tool

21 on; this effect likely involved the adhesion GPCR GPR56.

22 ind a close relationship with lipids for all GPCRs simulated, in particular, cholesterol and phosphat

23 the lipid-protein interaction profile of all GPCRs simulated to facilitate analysis and comparison of

24 palindromic repeats (CRISPR) engineering and GPCR ligand discovery.

25 Using deep variant profiling and GPCR assays in HEK293 cells, we assessed the pH-sensing

26 , endocytosis, and downstream signaling, and GPCR-betaarr complex formation can be used as a generic

27 findings suggest that when TRP channels and GPCRs are co-expressed in the same tissues, many of thes

28 isoform is uniquely coupled to both RTK and GPCRs.

29 and the lack of highly specific antibodies, GPCRs are still challenging to study in vivo.

30 e" and "tail" interaction model for arrestin-GPCR interaction.

31 n 2 receptor activates Src as efficiently as GPCR-betaarr complexes.

32 r that recognizes signaling proteins such as GPCRs and links them to the intraflagellar transport mac

33 chanism contrasts with the generally assumed GPCR activation mechanism, which proceeds through an ope

34 tem, establish a common mechanism of class B GPCR activation and G protein coupling, and provide a pa

35 s work advances our understanding of class B GPCR activation and Gs coupling.

36 Comparison with other class B GPCR structures reveals that PACAP27 engages VIP1R with

37 these provide coverage of the major class B GPCR subfamilies.

38 Recent structures of family B GPCR-G(s) protein complexes reveal a disruption in the a

39 e a thirty-three-member subfamily of Class B GPCRs that control a wide array of physiological process

40 brane protein-lipid interactions for class B GPCRs.

41 iven the structural conservation of class B1 GPCRs, the modulatory effects of GM3 and PIP(2) on GCGR

42 es for RAC1 on DOCK2(DHR2), and RHOG and BAI GPCRs on ELMO1.

43 tide sequence of ligands for peptide-binding GPCRs.

44 rminating signals initiated by agonist-bound GPCRs.

45 beta-arr/IGF1R interaction and controlled by GPCR-kinases (GRK), we explored GRKs as potential antica

46 on of G protein-coupled receptors (GPCRs) by GPCR kinases (GRKs) facilitates arrestin binding and rec

47 ylation of the C terminus of the receptor by GPCR kinases (GRKs) and by coupling of beta-arrestin 1 (

48 c activation of proto-oncogene kinase Src by GPCR-betaarr complexes in vitro and establish the confor

49 gun to unravel how these fundamental class C GPCR features impact the processes of ligand binding, re

50 hat beta-arrestin 2 (beta-Arr2), a canonical GPCR signaling partner, localizes in SECs with eNOS in a

51 terminus, a major component of the chemokine-GPCR interface.

52 ptor-1 (FPR1) is a member of the chemotactic GPCR-7TM formyl peptide receptor family, whose principle

53 Significantly, we demonstrate that chimeric GPCRs can be created with engineered nanobody binding si

54 Here we find that, upon activation, ciliary GPCRs become tagged with ubiquitin chains comprising K63

55 demonstrates that ubiquitination of ciliary GPCRs is required for their regulated exit from cilia.

56 ed the beneficial effects of Galphas-coupled GPCRs on reducing fibroblast activation and fibrosis.

57 PI3Kgamma isoform is activated by Gi-coupled GPCRs in myeloid cells, but the extent to which the two

58 contrast, Rgs proteins inhibit Gi/q-coupled GPCRs to negatively regulate PDA progression.

59 of the small G protein Cdc42 by G(s)-coupled GPCRs, inducing cytoskeletal rearrangements and formatio

60 Here we determine the structure of a class D GPCR, the Saccharomyces cerevisiae pheromone receptor St

61 contrast, there are no structures of class D GPCRs, which are found exclusively in fungi where they r

62 e GTP hydrolysis, and thereby rapidly dampen GPCR signaling.

63 basis of drug action at the level of defined GPCR interaction networks using proteomic approaches ena

64 ostable variants of experimentally demanding GPCRs.

65 ystallization screen that involves detecting GPCR expression levels in Spodoptera frugiperda (Sf9) cu

66 protein interaction profiles of 28 different GPCRs, spanning different levels of classification and c

67 ither into the loops or termini of different GPCRs, ion channels, receptors and transporters without

68 s high selectivity over a panel of different GPCRs, is able to cross the blood-brain barrier and acts

69 g hypothesis - that different agonists drive GPCRs to engage different cytoplasmic proteins in living

70 y PKI can act as a molecular switch, driving GPCR-Galphas-cAMP signaling toward activation of EPAC-RA

71 To date, only about 17% of druggable GPCRs have had their structures characterized at atomic

72 Together, we establish an engineered GPCR-ectodomain-based mimicry principle that differentia

73 -associated mutations tend to cause enhanced GPCR pathway activation to favor oncogenicity.

74 f9) culture by flow cytometry and evaluating GPCR stability by size-exclusion chromatography and UV a

75 oproteolysis occurs within the extracellular GPCR autoproteolysis-inducing (GAIN) domain that is prox

76 ll support a better understanding of Class F GPCR pharmacology.

77 ids in the modulation of class A and class F GPCR signaling properties, little is known about the eff

78 ate a parallel regulated endocytic cycle for GPCRs operating at the presynapse, separately from the s

79 chnique is utilized for measuring label-free GPCR signal profiles.

80 ma) are the main transducers of signals from GPCRs, mediating the action of countless natural stimuli

81 an also potentially assemble into functional GPCR heteromers.

82 The Galphas-GPCR complex detected with Nb37 displayed higher mobilit

83 Pharmacogenetic activation of Gq-GPCR signaling in sensory SGCs decreased heat-induced no

84 hypothesis that SGC Gq-coupled receptor (Gq-GPCR) signaling modulates pain sensitivity in vivo using

85 In a yeast-based assay, where heterologous GPCRs are coupled to chimeric G proteins, EMR2 showed br

86 -site identification, followed by homologous GPCR detections through structure and orthosteric bindin

87 Here, we determine how GPCR phosphorylation influences arrestin behavior by usi

88 s and provide fundamental information on how GPCR signaling is directed.

89 ngineered a yeast strain library of 30 human GPCRs and their 300 possible GPCR-Galpha coupling combin

90 ors, a feature distinct from all other human GPCRs.

91 e striatal astrocyte stimulation of the G(i)-GPCR pathway in vivo corrected several HD-associated ast

92 f alpha(2a)-AR heteroreceptors and BNST G(i)-GPCR signaling in stress-induced reinstatement of cocain

93 lectively, our data show that differences in GPCR-G protein coupling preferences, and the Galpha(o) s

94 uences on conformational changes involved in GPCR activation.

95 nd to play an unexpected stimulatory role in GPCR-mediated eNOS signaling.

96 roborate findings of mutational tolerance in GPCRs, even in conserved motifs, but reveal inherent con

97 GPCR expression by incrementally increasing GPCR gene copy number potentiates Galpha coupling of the

98 First, we demonstrate that increasing GPCR expression by incrementally increasing GPCR gene co

99 decade voltage modulation of ligand-induced GPCR activity has been reported for several GPCRs.

100 tissues, many of these channels can inhibit GPCR desensitization.

101 ological advances have provided insight into GPCR biology, which now facilitates deeper understanding

102 CyFIRplex) DCyFIR modes, recapitulated known GPCR agonism with 100% accuracy, and identified unexpect

103 quality, selectively stable isotope-labeled GPCR for studies by nuclear magnetic resonance.

104 integrates complementary methods for ligand-GPCR interaction recognition and thus significantly impr

105 files constructed from the homologous ligand-GPCR complexes are then used to thread through compound

106 ptor (GPCR), with more similarity to lipidic GPCRs than to the homologous peptidic GPCRs.

107 Many GPCR AAs modulate receptor signaling, but molecular deta

108 We conclude that Ub chains mark GPCRs and other unwanted ciliary proteins for recognitio

109 lts reveal that N-glycosylation can modulate GPCR function by altering receptor dynamics.

110 of using therapeutic antibodies to modulate GPCR signaling.

111 Most GPCR AAs are allosteric modulators and exhibit a broad r

112 This map of neurotransmitter GPCR expression and function in the egg-laying circuit p

113 We found that many neurotransmitter GPCRs are expressed in each neuron, that neurons also ap

114 rotein activating peptide derived from a non-GPCR regulator of G-proteins to a small plant protein do

115 he base of the finger loop that dictates non-GPCR interactions specifying beta-arrestin-dependent sig

116 dback cycle of enhanced neuronal tau via non-GPCR mechanisms.

117 through its evolutionarily conserved NPY/NPF GPCR, NPR-11, in downstream AIA interneurons.

118 tors and leverages the inherent allostery of GPCR-effector coupling.

119 enable equilibrium and real-time analyses of GPCR ligand engagement and consequent activation, measur

120 hich may help decipher additional aspects of GPCR signaling and regulation.

121 l hurdles to the successful determination of GPCR structure.

122 0gamma for Gbetagamma subunits downstream of GPCR activation.

123 ore fully understand the indirect effects of GPCR-targeted drugs on the cancer phenotype.

124 s (GPCRs), in vivo cellular heterogeneity of GPCR signaling and downstream transcriptional responses

125 ntial and (patho)physiological importance of GPCR pH sensing.

126 platform to characterize large libraries of GPCR variants in human cell lines with a barcoded transc

127 ISPR to build and profile large libraries of GPCR variants.

128 we focus on the opioid receptors, members of GPCR family A, and highlight recent advances in the fiel

129 ligand specificity by profiling mixtures of GPCR-barcoded yeast strains in a single tube.

130 Here, we review emerging modes of GPCR signaling via endosomal membranes and the physiolog

131 erlies the mechanism of ligand modulation of GPCR signaling in cells.

132 ng (RGS) proteins are critical modulators of GPCR signaling that dampen the activity of heterotrimeri

133 has been applied to an increasing number of GPCR targets over the past decade and now a few of these

134 e, our results provide a detailed picture of GPCR-lipid interactions.

135 ting the real-time, in situ dynamic range of GPCR activity.

136 ormation can be used as a generic readout of GPCR and betaarr activation.

137 One structural signature of GPCR activation is a large-scale movement (ca. 6 to 14 a

138 ughput-compatible addition to the toolbox of GPCR pharmacologists.

139 hich now facilitates deeper understanding of GPCR AA function at the molecular level.

140 om a canonical to a context-specific view of GPCR signalling that considers how combinatorial express

141 ry proteins can bias signaling downstream of GPCRs in response to their endogenous agonist.

142 olfactory receptors as the largest family of GPCRs catapulted olfaction into mainstream neurobiology.

143 A major function of GPCRs is to inhibit presynaptic neurotransmitter release

144 The propensity of GPCRs to adopt different signaling modes is largely enco

145 characterize in vivo interacting proteins of GPCRs, the largest family of membrane receptors with cru

146 nts for nearly the entire druggable space of GPCRs.

147 Crystal structures of GPCRs provide snapshots of their inactive and active sta

148 emergence of three-dimensional structures of GPCRs such as GLP-1R and glucagon receptor has helped to

149 d assay to overcome this challenge, based on GPCR-interacting biosensors that are disconnected from e

150 pected buffering role of GPR88 expression on GPCR signaling, with intriguing consequences for opioid

151 The consequences of these interactions on GPCR function and physiology lays the foundation for new

152 nsing mechanism in brown adipocytes via Opn3-GPCR signaling that can regulate fuel metabolism and mit

153 tatin receptor 3 (SSTR3) and from the orphan GPCR GPR161 demonstrates that ubiquitination of ciliary

154 SMO) reveals that SMO, and likely also other GPCR cargoes, must release their amphipathic helix 8 fro

155 However, the activation mechanism of other GPCR classes remains more elusive, in large part due to

156 dout will prove useful to the study of other GPCR families and the development of new therapeutics.

157 comparisons with orthologues and with other GPCR classes.

158 h, may predispose the AT1R and certain other GPCRs (such as chemokine receptors) to adopt conformatio

159 should prove directly translatable to other GPCRs, providing a new tool for ligand discovery and mut

160 accessory proteins, and crosstalk with other GPCRs.

161 GPCRs, and analogous mutations within other GPCRs similarly impaired beta-arrestin recruitment while

162 ts and water molecules for these peptidergic GPCR targets.

163 ipidic GPCRs than to the homologous peptidic GPCRs.

164 ese data demonstrate that the phosphorylated GPCR tail interaction with betaarr1 is necessary and suf

165 ary of 30 human GPCRs and their 300 possible GPCR-Galpha coupling combinations.

166 nule cells of the OB of Bai3, a postsynaptic GPCR that binds C1ql3, similarly suppressed synaptic tra

167 modifications for stabilization of purified GPCR in detergent micelles.

168 Activating G(q)-GPCR signaling in PFC astrocytes increased drinking in e

169 Resurging interest in identifying RAMP-GPCR interactions has recently been fueled by coevolutio

170 ocesses regulate G protein-coupled receptor (GPCR) activity.

171 ery strategy for G protein-coupled receptor (GPCR) biased drug screening.

172 G protein-coupled receptor (GPCR) biogenesis, trafficking, and function are regulate

173 The class B G protein-coupled receptor (GPCR) calcitonin receptor (CTR) is a drug target for ost

174 R88 is an orphan G protein-coupled receptor (GPCR) considered as a promising therapeutic target for n

175 se regulation of G protein coupled receptor (GPCR) desensitization.

176 t a panel of 168 G protein-coupled receptor (GPCR) drug targets.

177 eptor (D2R) is a G protein-coupled receptor (GPCR) expressed in regions of the brain that control mot

178 med GPR120, is a G protein-coupled receptor (GPCR) for medium and long-chained fatty acids, agonism o

179 The orphan G protein-coupled receptor (GPCR) GPR84 is expressed on immune cells mediating proin

180 1R) is a class B G protein-coupled receptor (GPCR) involved in metabolism.

181 ctors, including G protein-coupled receptor (GPCR) kinase interactor 1 (GIT1), which we found to play

182 G protein-coupled receptor (GPCR) kinases (GRKs) play a key role in terminating sign

183 ctively activate G protein-coupled receptor (GPCR) signaling pathways beneficial in treating a diseas

184 hat mutations in G protein-coupled receptor (GPCR) signaling pathways in cancer are more prominent th

185 used to profile G protein-coupled receptor (GPCR) signaling pathways in living cells.

186 tially stimulate G protein-coupled receptor (GPCR) signaling through one intracellular pathway versus

187 riatal astrocyte G protein-coupled receptor (GPCR) signaling.

188 belonging to the G protein-coupled receptor (GPCR) superfamily.

189 ch belong to the G protein-coupled receptor (GPCR) superfamily.

190 (beta(1)AR) is a G-protein-coupled receptor (GPCR) that couples(1) to the heterotrimeric G protein G(

191 en-transmembrane G protein-coupled receptor (GPCR) that regulates blood glucose levels.

192 s a prototypical G protein-coupled receptor (GPCR) where new pharmacological, signalling and cell bio

193 ane heptahelical G protein-coupled receptor (GPCR) with the potential to produce a nonvisual photorec

194 ocket of a human G protein-coupled receptor (GPCR) yielding variants with 4-fold greater affinity to

195 A novel human G protein-coupled receptor (GPCR), known as Mas-related GPCR-X2 (MRGPRX2, mouse orth

196 sm for a class B G-protein-coupled receptor (GPCR), the glucagon receptor.

197 PGCs utilize a G protein coupled receptor (GPCR), Tre1, to guide front-back migratory polarity radi

198 urally divergent G protein-coupled receptor (GPCR), with more similarity to lipidic GPCRs than to the

199 A photosensitive G protein-coupled receptor (GPCR), yet relatively few pharmaceutical agents targetin

200 l expression of G protein-coupled receptors (GPCR) reflects their involvement in most physiological p

201 tegral membrane G protein-coupled receptors (GPCR) requires thorough understanding of ligand binding

202 Among class A G protein-coupled receptors (GPCR), the human adenosine A(2A) receptor (hA(2A)AR) rem

203 ptides activate G protein-coupled receptors (GPCRs) - nearly 50 GPCR peptide drugs have been approved

204 s activation of G protein-coupled receptors (GPCRs) and association of active receptors with G protei

205 dulator of both G protein-coupled receptors (GPCRs) and insulin signaling.

206 xpress numerous G protein-coupled receptors (GPCRs) and thus mice lacking the stimulatory subunit of

207 G protein-coupled receptors (GPCRs) are a large family of integral membrane proteins

208 G-protein-coupled receptors (GPCRs) are a ubiquitously expressed family of receptor p

209 G protein-coupled receptors (GPCRs) are biologic switches that transduce extracellula

210 These G protein-coupled receptors (GPCRs) are broadly expressed and are particularly import

211 G protein-coupled receptors (GPCRs) are crucial for establishing the resolution phase

212 G protein-coupled receptors (GPCRs) are important membrane proteins in higher eukaryo

213 G protein-coupled receptors (GPCRs) are important modulators of glucose-stimulated in

214 Class B G protein-coupled receptors (GPCRs) are important therapeutic targets for major disea

215 G-protein-coupled receptors (GPCRs) are major signaling proteins that undergo multipl

216 G-protein-coupled receptors (GPCRs) are membrane proteins that modulate physiology ac

217 G protein-coupled receptors (GPCRs) are membrane-bound proteins that depend on their

218 Multiple G protein-coupled receptors (GPCRs) are targets in the treatment of dementia, and the

219 G protein-coupled receptors (GPCRs) are the largest class of transmembrane receptors

220 sphorylation of G protein-coupled receptors (GPCRs) by GPCR kinases (GRKs) facilitates arrestin bindi

221 ptors (FPRs) as G protein-coupled receptors (GPCRs) can recognize formylpeptides derived from pathoge

222 geting class B1 G-protein-coupled receptors (GPCRs) can treat multiple diseases; however, there remai

223 G protein-coupled receptors (GPCRs) comprise a large class of integral membrane prote

224 G-protein-coupled receptors (GPCRs) comprise the largest and most pharmacologically t

225 More than 800 G protein-coupled receptors (GPCRs) comprise the largest class of membrane receptors

226 G protein-coupled receptors (GPCRs) comprise the largest group of membrane receptors

227 trafficking of G protein-coupled receptors (GPCRs) controls cilium-based signaling pathways.

228 How G protein-coupled receptors (GPCRs) evoke specific biological outcomes while utilizin

229 A variety of G protein-coupled receptors (GPCRs) have been implicated in the pathogenesis of pulmo

230 ural studies on G-protein-coupled receptors (GPCRs) have flourished recently, providing long-sought i

231 Of the 800 G protein-coupled receptors (GPCRs) in humans, only three (GPR4, GPR65, and GPR68) re

232 terplay between G protein-coupled receptors (GPCRs) is critical for controlling neuronal activity tha

233 onist-activated G protein-coupled receptors (GPCRs) must correctly select from hundreds of potential

234 trafficking of G protein-coupled receptors (GPCRs) out of cilia is mediated by the BBSome.

235 nding protein (G protein)-coupled receptors (GPCRs) play important roles in carbohydrate metabolism.

236 CD) of class B1 G-protein-coupled receptors (GPCRs) plays a central role in signal transduction and i

237 sed agonists of G protein-coupled receptors (GPCRs) preferentially activate a subset of downstream si

238 by an agonist, G-protein-coupled receptors (GPCRs) recruit beta-arrestin, which desensitizes heterot

239 G-protein coupled receptors (GPCRs) represent a significant target class for pharmace

240 G protein-coupled receptors (GPCRs) signal through allostery, and it is increasingly

241 ar signals from G protein-coupled receptors (GPCRs) to intracellular effectors.

242 ) interact with G-protein-coupled receptors (GPCRs) to modify their functions, imparting significant

243 seven out of 35 G-protein coupled receptors (GPCRs) within the germline cells also eliminated the cap

244 l importance of G protein-coupled receptors (GPCRs), in vivo cellular heterogeneity of GPCR signaling

245 dies of class A G protein-coupled receptors (GPCRs), such as rhodopsin and the beta(2) adrenergic rec

246 studying human G protein-coupled receptors (GPCRs), the largest class of membrane receptors in human

247 d primarily for G protein-coupled receptors (GPCRs), there are also reports of ligand bias for recept

248 ass C family of G-protein-coupled receptors (GPCRs)-mediates inhibitory neurotransmission and has bee

249 bers of class B G-protein-coupled receptors (GPCRs).

250 ocyte-expressed G protein-coupled receptors (GPCRs).

251 g signaling via G-protein coupled receptors (GPCRs).

252 Here, we show that opioid peptide receptors, GPCRs that mediate highly sensitive presynaptic inhibiti

253 How TRP channels reciprocally regulate GPCR signaling is less well-explored.

254 oupled receptor (GPCR), known as Mas-related GPCR-X2 (MRGPRX2, mouse ortholog, MrgprB2), has recently

255 ent applies to GRK2, a biologically relevant GPCR regulator, through discrete interactions of GRK2 wi

256 , thus providing a strategy to develop safer GPCR-targeting therapeutics with more directed pharmacol

257 The class B secretin GPCR (SecR) has broad physiological effects, with target

258 cations for design of functionally selective GPCR-targeted drugs.

259 rug design to develop more subtype-selective GPCR ligands with potentially reduced side effects and p

260 GPCR activity has been reported for several GPCRs.

261 lipid-protein interaction profile of several GPCRs hint at an intricate relationship of these recepto

262 Since GPCRs can transactivate receptor tyrosine kinases, we al

263 We show how a single GPCR gene can diversify into several isoforms with disti

264 se interactions is dependent on the specific GPCR as well as its conformational state.

265 t how protocols that were developed to study GPCR signaling can be used to identify and quantify RTK

266 ding to p110gamma is insufficient to support GPCR activation in this cell type.

267 tween ligands and their cognate HiBiT-tagged GPCRs through competitive binding with fluorescent trace

268 f novel specific pharmaceuticals that target GPCRs, but such studies require expression of significan

269 n, nausea, and anxiety, many of which target GPCRs.

270 Our results demonstrate that GPCR activation by a protein agonist does not always req

271 To test the hypothesis that GPCR-induced calcium signaling is also involved in the b

272 Together, our data suggest that GPCR heteromerization may itself represent a mechanism o

273 communicate with other cell types, and that GPCRs appear to often act redundantly or only under spec

274 A major advantage of DCyFIR is that GPCRs and other assay components are CRISPR-integrated d

275 e plasma membrane, it is now recognized that GPCRs signal also at various intracellular locations, an

276 The GPCR-betaarr interaction critically contributes to GPCR

277 actions of the BBSome with membranes and the GPCR Smoothened (SMO) reveals that SMO, and likely also

278 es in the transmembrane alpha-helices of the GPCR CXCR4.

279 coupling efficiency varies depending on the GPCR-G protein pair.

280 ies in other organ systems that express this GPCR, such as the lung, testes, and small intestine.

281 E STATEMENT Neurotransmitters signal through GPCRs to modulate activity of neurons, and changes in su

282 etaarr interaction critically contributes to GPCR desensitization, endocytosis, and downstream signal

283 r measuring arrestin recruitment kinetics to GPCRs using a high quantum yield, genetically encoded fl

284 lesterol and PIP lipids bind specifically to GPCRs, they utilize distinct mechanisms.

285 Adhesion-type GPCRs (aGPCRs) participate in a vast range of physiologi

286 ics of the allosteric network that underlies GPCR activation.

287 Understanding GPCR AAs is not only important for defining how these un

288 g circuit provides a model for understanding GPCR signaling in other neural circuits.SIGNIFICANCE STA

289 efforts to tap the potential of understudied GPCRs by developing yeast-based technologies for high-th

290 ore, uncovering the function of understudied GPCRs provides a wealth of untapped therapeutic potentia

291 A unique GPCR that is known to require heterodimerization for fun

292 tment and trafficking for several unmodified GPCRs.

293 nly important for defining how these unusual GPCR modulators function in disease, but also provides i

294 erimental evidence indicate that widely used GPCR-targeted drugs may promote or inhibit cancer progre

295 y inputs in the model building process using GPCRs as a focus to improve the pipeline in two critical

296 These assays utilize GPCRs genetically fused to an N-terminal HiBiT peptide (

297 and p84/p110gamma in neutrophils by various GPCR agonists.

298 currently available approaches to visualize GPCR-betaarr1 binding, which may help decipher additiona

299 ions provide a novel mechanism through which GPCRs regulate cocaine's pharmacological and behavioral

300 deubiquitinases that are either linked with GPCR trafficking or localized on endosomes, we identifie